Nature Communications · 2023 · 54 citations · 89 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologyTumor MicroenvironmentCancer EpigenomicsCancer TranscriptomicsMetastatic Niche FormationSingle-cell EpigenomicsSingle-cell TranscriptomicsTumor-associated MacrophagesBone Marrow DisseminationCell-type-specific Epigenomic ProfilingDifferential Cell-type Composition AnalysisMetastatic Niche SignalingMetastatic Tumor MicroenvironmentSingle-cell Analysis Of MetastasisSingle-cell Epigenomic ProfilingTumor Microenvironment Heterogeneity
Metastasis is the major cause of cancer-related deaths. Neuroblastoma (NB), a childhood tumor has been molecularly defined at the primary cancer site, however, the bone marrow (BM) as the metastatic niche of NB is poorly characterized. Here we perform single-cell transcriptomic and epigenomic profiling of BM aspirates from 11 subjects spanning three major NB subtypes and compare these to five age-matched and metastasis-free BM, followed by in-depth single cell analyses of tissue diversity and cell-cell interactions, as well as functional validation. We show that cellular plasticity of NB tumor cells is conserved upon metastasis and tumor cell type composition is NB subtype-dependent. NB cells signal to the BM microenvironment, rewiring via macrophage mgration inhibitory factor and midkine signaling specifically monocytes, which exhibit M1 and M2 features, are marked by activation of pro- and anti-inflammatory programs, and express tumor-promoting factors, reminiscent of tumor-associated macrophages. The interactions and pathways characterized in our study provide the basis for therapeutic approaches that target tumor-to-microenvironment interactions.
89
An integrated encyclopedia of DNA elements in the human genome
Integrated analysis of multimodal single-cell data
Yuhan Hao, Stephanie Hao, Erica Andersen‐Nissen et al. · Cell · 2021 · 16K citations · Full text
Hallmarks of Cancer: New Dimensions
Cancer Discovery · 2022 · 9.1K citations · Full text
Medicine, Cancer Biology, Oncology +17